跳至主要内容
临床试验/NCT05203354
NCT05203354已完成4 期

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Mahmoud Ahmed Ali Ahmed1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Decrease Omentin-1 serum level in both groups treated with NB-UVB and Acitretin

研究概览

简要总结

Studying the effects of Narrowband Ultraviolet B versus acitretin on psoriatic patients

详细描述

Compare the effects of Narrowband Ultraviolet B versus acitretin on serum Omentin-1 level in psoriatic patients as case control study by dividing patients into 3 groups: group 1 include patients receive Narrowband Ultraviolet B, group II includes patients receive acitretin (0.5-1 mg/day) and control group. The duration of this study about 3 months after receving those interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes with psoriasis vulgaris.

排除标准

  • • Patients with history of malignancies, renal and liver diseases.
  • Patients received NB-UVB phototherapy in the last 6 months.
  • Patients treated with methotrexate or biologic agents and any systemic treatment of psoriasis.

研究组 & 干预措施

NB-UVB group

Active Comparator

Patients who receive Narrowband ultraviolet B phototherapy

干预措施: Narrowband Ultraviolet B (Radiation)

Acitretin group

Active Comparator

Patients who receive acitretin

干预措施: Acitretin (Drug)

结局指标

主要结局

Decrease Omentin-1 serum level in both groups treated with NB-UVB and Acitretin

时间窗: 3 months

This outcome indicates potential role of Omentin-1 in psoriasis pathogenesis and its involvement in pathogenesis of obesity and related diseases as metabolic syndrome. So it will be concluded that high levels of this protein could be marker against obesity and related disorders including psoriasis. Omentin-1 can be valuable marker for psoriasis severity detected by its correlation with psoriasis area severity index (PASI) score and for evaluating the therapeutic outcomes

次要结局

  • Decrease PASI score in psoriatic patients(3 months)

研究者

发起方
Mahmoud Ahmed Ali Ahmed
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mahmoud Ahmed Ali Ahmed

Assistant lecturer

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验